Menu
Menu
The Oncology Institute Blog
The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting
TOI to attend the conference June 2-6 in Chicago CERRITOS, Calif., May 31, 2023 (GLOBE NEWSWIRE) — The Oncology Institute (NASDAQ: TOI), one of the
Read More →
May is Skin Cancer Awareness Month
May is Skin Cancer Awareness Month, a time to bring attention to the prevention and treatment of one of the most common forms of cancer.
Read More →
Learn the Facts: Five Lung Cancer Myths
Lung cancer affects a large number of people each year, making it the third most common type of cancer in the US.1 Unfortunately, it is
Read More →
The Oncology Institute Rebrands Clinical Trials Division
Innovative Clinical Research Institute Will Become TOI Clinical Research The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the
Read More →
5 Fast Facts: Myths About Prostate Cancer
Prostate cancer affects men second most commonly after skin cancer. Take 5 minutes to read about the prostate and some common myths about prostate cancer.
Read More →
The Oncology Institute Enrolls Nation’s First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib
Value-based Oncology Leader Improving Access to Cutting-Edge Therapies CERRITOS, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: TOI), today announces the
Read More →
© 2022 The Oncology Institute of Hope and Innovation. All rights reserved.